Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

A Quick Guide to Buprenorphine Products

By Eric Ketcham, MD, MBA, FACEP, FASAM, FACHE | on October 23, 2018 | 10 Comments
Pharm 360
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Many patients buy bupe, administering their own medication-assisted treatment. When patients speak of treating their symptoms or self-medicating with “strips,” they are usually speaking of 8 mg/2 mg bupe/naloxone film strips. Clearly, bupe does have street value. However, the street value of bupe is far less than that of other prescription opioids.

You Might Also Like
  • Suboxone 101: The Skinny on This Opioid-Dependence Drug
  • Reader Raises 2 Issues with Buprenorphine Article
  • Indivior, Drug to Fight Opioid Addiction, Approved by U.S. FDA
Explore This Issue
ACEP Now: Vol 37 – No 10 – October 2018

Injectable Buprenorphine

Buprenex, the common brand of injectable bupe, comes in 0.3 mg/1 mL vials. Bupe is a potent analgesic, and as an analgesic, bupe 0.3 mg IV is equivalent to about 7.5 mg of IV morphine. However, it has a much longer half-life. Of note, although the half-life of bupe as an analgesic is only about eight hours, its half-life when treating OUD is much longer (about 36 hours) but is dose-dependent.

The IV form of bupe is not commonly used in the United States but has been used as an IV analgesic in other parts of the world since the 1980s. The use of injectable bupe is growing in American veterinary medicine. Due to its much higher affinity for the mu receptor, IV bupe has also been used in some emergency departments to reverse acute opioid overdoses.3

Transdermal Buprenorphine Patches

Butrans is the brand name of the transdermal bupe patches used to treat chronic pain. While Butrans may be effective in treating OUD, it is not usually prescribed for OUD, and it has a U.S. Food and Drug Administration (FDA) indication only for chronic pain in the “opioid-experienced” patient. Generally, patients are switched to Butrans patches after developing a tolerance to traditional opioids.

The patches come in dosing strengths of 5, 7.5, 10, 15, and 20 mcg/hour and are changed every seven days. The 10 mcg/hour patch is approximately equianalgesic to 80 mg/day of oral morphine. Note that bupe patches, intended for the opioid-dependent patient, release much fewer mcg/hour of buprenorphine than fentanyl patches do of fentanyl.

Implantable Buprenorphine

Probuphine is a long-term implantable form of buprenorphine that delivers a continuous, stable blood level of bupe for the treatment of OUD. Four implants inserted subdermally in the upper arm (in an office procedure) release a total dose of bupe similar to a daily sublingual 8 mg dose for six months. The dose equivalent of only 8 mg/day SL is lower than the effective dose for most patients treated for OUD with bupe SL. This low equivalent dose along with the cost and the need to obtain insurance approval are factors that prevent more widespread use.

Depot Subcutaneous Buprenorphine

Sublocade is the newest long-acting form of bupe on the market, FDA-approved in late 2017 for treating OUD. This depot form of bupe is injected monthly in 100 mg and 300 mg doses into the abdominal subcutaneous tissue to continuously release a dosage equivalent to 8–24 mg/day of SL bupe. Although more patients with OUD could more easily remain compliant in bupe medication-assisted treatment, the number of patients receiving Sublocade remains low. The cost and the need to obtain insurance approval are factors that prevent more widespread use.

Pages: 1 2 3 | Single Page

Topics: BuprenexButransDrug AbuseOpioid CrisisProbuphineSublocadeSuboxoneZubsolv

Related

  • How to Manage Elderly Patient Pain without Opioids

    February 13, 2024 - 0 Comment
  • Are Opiates Futile in Low Back Pain?

    October 15, 2023 - 0 Comment
  • September 2023 News from the College

    August 29, 2023 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

10 Responses to “A Quick Guide to Buprenorphine Products”

  1. November 7, 2019

    Linda Trplette Reply

    All I want to know is which is stronger soboxin 8 mg or belbuca 75 mcg

    • August 24, 2020

      Amanda Reply

      Mcg is micrograms and mg is milligrams, mg is more!

      • October 25, 2020

        Cody Lehner Reply

        While that is true, it doesn’t make one medication in milligrams strings than a different medication doses in micrograms. They don’t have the exact same conversion.

  2. January 11, 2020

    TDavis Reply

    Is there a such thing as buprenorphine strips

    • September 22, 2020

      Alexi Reply

      There is a form of this medication that comes in a dark orange what feels like plastic. Its not the film. How is this form used? Is it like the films?

      • September 22, 2020

        ALEXI Reply

        I meant to ask my own question. Not reaspond to yours.

  3. July 12, 2020

    Kevin Reply

    Yes the strips come in 2mg,4mg,8mg and 12mg. The max dose allowed per day is 24mg so depending on your need the doctor will prescribe all the way up to that amount and divide it up such as an 8mg three times a day or a 12mg twice a day.

  4. August 6, 2020

    Ken Reply

    Who manufactures the best sublingual buprenorphine tablet product? Meaning one that dissolves and has the best bioavailability. The ones we are using don’t completely dissolve in an hour.

  5. August 28, 2020

    Deborah Moore Reply

    Ken is it for pain or addiction. It’s beyond me why the fda seperates it buprenorphine is buprenorphine but anyway look into belbuca.

  6. October 10, 2020

    Jody Reply

    I’m currently on 8mg buprenorphine sl tablets 3x a day but just stumbled onto the knowledge of there being transdermal patches of buprenorphine as well.. im not very good at taking my meds on time, basically remembering only when the sickness creeps over my body that I’m late on my does. ive read there is 5mcg all the way too 20mcg for the transdermal patches.. would this be an option I could potentially ask about? what is the equivalence from an X amount mcg per hr, 7 day transdermal patch to my current 8mg sl tablet, 3x a day does? all I can find is equivalence charts on everything else “opioid” but nothing on the same drug just different in the way its prescribed to be taken.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603